AB Science, Ales, Bastide, Naturex : French Equity Preview
The following companies’ shares may be active in Paris. Symbols are in parentheses after company names and prices are from the last close.
AB Science SA (AB) : The French drugmaker plans to sell 7.5 million euros ($10.8 million) of convertible bonds. The bonds will pay interest of 1.25 percent and are convertible into stock at a price of 12.65 euros a share. The shares gained 15 percent to 7.85 euros.
Ales Groupe (ALPHY) : The maker of Laboratoires Lierac cosmetics said second-quarter revenue rose to 52.4 million euros from 43.5 million euros. The shares rose 1.4 percent to 12.43 euros.
Avenir Telecom (AVT) SA: The distributor of mobile telecommunications equipment said first-quarter revenue fell to 103.2 million euros from 129 million euros. The shares fell 1.4 percent to 71 euro cents.
Bastide le Confort Médical (BLC FP): The provider of home health-care services said full-year revenue rose 9.2 percent to 109.1 million euros. The shares fell 0.4 percent to 7.70 euros.
Naturex (NRX) : The producer of natural vegetable ingredients and extracts said first-half net income rose to 9.7 million euros from 7.6 million euros. The stock rose 0.5 percent to 53.58 euros.
To contact the editor responsible for this story: Melissa Pozsgay at firstname.lastname@example.org.